Finance

Beta
Lists
BIOSGN:STO
Biosergen AB
SEK 8.90
0.00%
(0.00) 1D
Jun 3, 5:00:00 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for BIOSGN...
Open
SEK 8.90
High
SEK 9.00
Low
SEK 8.90
Mkt. cap
20.90M
Avg. vol.
1.92K
Volume
195.00
52-wk high
SEK 67.80
52-wk low
SEK 8.90
EPS
-SEK 17.38
Shares outstanding
2.35M
No. of employees
1
Open
SEK 8.90
High
SEK 9.00
Low
SEK 8.90
Mkt. cap
20.90M
Avg. vol.
1.92K
Volume
195.00
52-wk high
SEK 67.80
52-wk low
SEK 8.90
EPS
-SEK 17.38
Shares outstanding
2.35M
No. of employees
1
News stories
From sources across the web
About Biosergen AB
CEOTine Kold Olesen
Employees1
Founded2004
Headquarters-
SectorBiotechnology
Websitebiosergen.net
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
285.00K
1.67M
131.00K
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.85M
12.35M
12.73M
11.37M
Operating expense
5.14M
11.04M
12.19M
12.49M
Total operating expenses
5.14M
11.04M
12.19M
12.49M
Operating income
-5.14M
-11.04M
-12.19M
-12.49M
Other non operating income
-
-
-
1.00K
EBT including unusual items
-5.15M
-11.04M
-12.17M
-12.46M
EBT excluding unusual items
-5.15M
-11.04M
-12.17M
-12.46M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
285.00K
-1.31M
-537.00K
1.12M
Net income
-5.15M
-11.04M
-12.17M
-12.46M
Net profit margin
-
-
-
-
Earnings per share
-2.00
-5.00
-5.00
-
Interest and investment income
-
-
22.00K
27.00K
Interest expense
-10.00K
-
-
-
Net interest expenses
-10.00K
-
22.00K
27.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer